{"id":"W3148345241","doi":"10.1200/jco.20.03639","title":"Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Palbociclib; Oncology; Internal medicine; Lapatinib; Taxane; Breast cancer; Letrozole; Estrogen receptor; Hormone receptor; Aromatase inhibitor; Gynecology; Tamoxifen; Cancer; Trastuzumab; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008269362,0.0007275185,0.001140352,0.0002235911,0.0001727983,0.0007097357,0.0005026222,0.0005356176,0.007812306],"category_scores_gemma":[0.0005728138,0.0001507237,0.0005828456,0.0002703201,0.0003489878,0.0004077643,0.0002349203,0.001680459,0.0007556753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004897054,"about_ca_system_score_gemma":0.0005455256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00061987,"about_ca_topic_score_gemma":0.001456927,"domain_scores_codex":[0.9997985,0.00009393355,0.00001041674,0.00003490076,0.00002725285,0.00003502677],"domain_scores_gemma":[0.9997972,0.00004795985,0.00003172363,0.00001225128,0.00001284036,0.00009801066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6703422,0.006085049,0.004311251,0.003062065,0.001433061,0.0002509339,0.00006535908,0.00194571,0.007927939,0.0009584847,0.01446054,0.2891574],"study_design_scores_gemma":[0.8969511,0.07242636,0.01247753,0.0003757846,0.0007859123,0.0005217472,0.00005090714,0.002052692,0.001846373,0.0007621622,0.01172545,0.00002394155],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8935021,0.06958609,0.001755305,0.001839113,0.0006918959,0.004621175,0.00518819,0.0003228805,0.02249319],"genre_scores_gemma":[0.9640443,0.01450566,0.001099944,0.002047827,0.0003532207,0.002708652,0.004044039,0.00002539439,0.01117099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007812306,"threshold_uncertainty_score":0.02613473,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08584686499972378,"score_gpt":0.4566029099254679,"score_spread":0.3707560449257442,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}